ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2810

The Impact of Psychiatric Comorbidity on Health Care Utilization for Youth with Systemic Lupus Erythematosus

Andrea M. Knight1,2, Alaina M. Davis3, Marisa S. Klein-Gitelman4, Zuleyha Cidav5 and David Mandell6, 1Division of Rheumatology, Center for Pediatric Clinical Effectiveness & PolicyLab, Children's Hospital of Philadelphia, Philadelphia, PA, 2Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 3Pediatric Rheumatology, Monroe Carell Junior Children's Hospital at Vanderbilt, Division of Pediatric Rheumatology, Nashville, TN, 4Division of Pediatric Rheumatology/PDD PTD, Lurie Children's Hospital of Chicago/Northwestern University, Chicago, IL, 5Perelman School of Medicine, Center for Mental Health Policy and Services Research, University of Pennsylvania, Philadelphia, PA, 6Psychiatry and Pediatrics, Center for Mental Health Policy and Services Research, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Adolescent, health care utilization, Lupus, mental health and psychiatric

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 7, 2017

Title: Systemic Lupus Erythematosus – Clinical Aspects and Treatment IV: Neuropsychiatric Disease and Health Economics

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Youth with systemic lupus erythematosus (SLE) have high health care utilization, which may be exacerbated by psychiatric disorders, a common comorbidity in this group. We examined the impact of psychiatric diagnoses on utilization of medical services in youth with SLE.

Methods : We conducted a retrospective cohort study using administrative claims for 2000 to 2013 from ClinformaticsTM DataMart (OptumInsight, Eden Prairie, MN), a large US database of privately insured enrollees. We included youth ages 10-24 years with an incident diagnosis of SLE (³3 International ClassiÞcation of Diseases, Ninth Revision codes for SLE 710.0, each >30 days apart, with ≥ 1 year of preceding continuous enrollment without a code for SLE). We categorized mutually exclusive groups of youth with SLE as those with: 1) no psychiatric diagnosis, 2) a psychiatric diagnosis in the 12 months preceding SLE diagnosis, and 3) an incident psychiatric diagnosis in the 12 months after SLE diagnosis. We calculated mean ambulatory, emergency and inpatient visits for medical services in the year after SLE diagnosis, and used Poisson regression to compare the number of visits among the 3 groups, adjusting for demographic and disease variables.

Results :  We identified 650 youth with an incident diagnosis of SLE, with mean age of 18.4 years (SD 3.7), composed of 88% females and 25% with nephritis. Depression was diagnosed in 144 (22%), anxiety in 93 (14%), and other psychiatric disorders in 210 (32%). A psychiatric diagnosis was present preceding SLE diagnosis in 122 (19%) and diagnosed in the year after SLE diagnosis in 105 (16%); 423 (65%) had no psychiatric diagnosis. In adjusted models, mean ambulatory visits in the year after SLE diagnosis were higher for those with preceding (14.4, SD 11.7, p=0.01) and incident (18.1, SD 14.6, p<0.0001) psychiatric diagnoses than among those without a psychiatric diagnosis (11.6, SD 9.9) (Figure). Those with an incident psychiatric diagnosis had more acute care visits compared to those without a psychiatric diagnosis: 9.5 (10.9) vs 5.1 (8.6) for emergency (p=0.0001), and 4.9 (10.7) vs 2.8 (7.8) for inpatient (p=0.03). Those with a preceding psychiatric diagnosis had 6.9 (13.1) mean emergency and 3.5 (8.2) mean inpatient visits, which were not significantly statistically different from the other groups.

Conclusion : In youth with SLE, psychiatric comorbidity is associated with higher utilization of medical services in ambulatory settings in the year after SLE diagnosis, and those with a new psychiatric diagnosis during this period had higher utilization of acute medical care. Interventions to address existing and newly identified psychiatric disorders may decrease health care burden for youth with SLE.


Disclosure: A. M. Knight, Childhood Arthritis & Rheumatology Research Alliance, Lupus Research Alliance, 2; A. M. Davis, None; M. S. Klein-Gitelman, Janssen Pharmaceutica Product, L.P., 2,Pfizer Inc, 2,UCB biosciences, 2,Abbvie, 2,Lupus Foundation of America, 2,NIH/LFA/Cure JM/Arthritis Foundation, 2,Up to Date, 7; Z. Cidav, None; D. Mandell, None.

To cite this abstract in AMA style:

Knight AM, Davis AM, Klein-Gitelman MS, Cidav Z, Mandell D. The Impact of Psychiatric Comorbidity on Health Care Utilization for Youth with Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/the-impact-of-psychiatric-comorbidity-on-health-care-utilization-for-youth-with-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-impact-of-psychiatric-comorbidity-on-health-care-utilization-for-youth-with-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology